Cargando…
Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population
Predicting pathogenic germline variants (PGVs) in breast cancer patients is important for selecting optimal therapeutics and implementing risk reduction strategies. However, PGV risk factors and the performance of prediction methods in the Japanese population remain unclear. We investigated clinicop...
Autores principales: | Senda, Noriko, Kawaguchi‐Sakita, Nobuko, Kawashima, Masahiro, Inagaki‐Kawata, Yukiko, Yoshida, Kenichi, Takada, Masahiro, Kataoka, Masako, Torii, Masae, Nishimura, Tomomi, Kawaguchi, Kosuke, Suzuki, Eiji, Kataoka, Yuki, Matsumoto, Yoshiaki, Yoshibayashi, Hiroshi, Yamagami, Kazuhiko, Tsuyuki, Shigeru, Takahara, Sachiko, Yamauchi, Akira, Shinkura, Nobuhiko, Kato, Hironori, Moriguchi, Yoshio, Okamura, Ryuji, Kan, Norimichi, Suwa, Hirofumi, Sakata, Shingo, Mashima, Susumu, Yotsumoto, Fumiaki, Tachibana, Tsuyoshi, Tanaka, Mitsuru, Togashi, Kaori, Haga, Hironori, Yamada, Takahiro, Kosugi, Shinji, Inamoto, Takashi, Sugimoto, Masahiro, Ogawa, Seishi, Toi, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353892/ https://www.ncbi.nlm.nih.gov/pubmed/34036661 http://dx.doi.org/10.1111/cas.14986 |
Ejemplares similares
-
Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants
por: Inagaki-Kawata, Yukiko, et al.
Publicado: (2020) -
Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer
por: Yamaga, Iku, et al.
Publicado: (2018) -
Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer
por: Takada, Masahiro, et al.
Publicado: (2022) -
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
por: Suzuki, Eiji, et al.
Publicado: (2015) -
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
por: Yamaguchi, Ayane, et al.
Publicado: (2021)